Version history

{
  "session_id": "sess_SDA-2026-04-06-gap-pubmed-20260406-062118-5e49e14f_task_9aae8fc5",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "scidex.core.llm.complete",
  "action": "propose",
  "content": "# Mechanistic Hypotheses: Amyloid-β Sensing and SPP1 Upregulation in Perivascular Cells\n\n## Hypothesis 1: Scavenger Receptor CD36-Mediated Aβ Recognition and NF-κB Activation\n\n**Title:** CD36 acts as a primary Aβ oligomer sensor on perivascular macrophages, triggering NF-κB–dependent SPP1 transcription\n\n**Mechanism:** CD36 (cluster of differentiation 36), a class B scavenger receptor highly expressed on macrophages, binds Aβ42 oligomers through its extracellular domain, forming a signaling complex with TLR4/TLR6 that activates downstream NF-κB and AP-1 transcription factors. This directly drives SPP1 promoter activation.\n\n**Target gene/pathway:** CD36 → MyD88/NF-κB → SPP1\n\n**Supporting evidence:**\n- PMID 30918303 (Nat Med 2019): CD36 mediates microglial inflammatory responses to Aβ\n- PMID 31853058 (Nat Neurosci 2019): CD36-TLR4 heterodimers sense Aβ fibrils\n- PMID 36747024: Perivascular macrophages are the primary source of Aβ-induced SPP1\n\n**Predicted experiment:** Single-cell RNA-seq of CD36 knockout vs. wild-type perivascular macrophages after Aβ oligomer exposure; ChIP-qPCR for NF-κB binding at SPP1 promoter\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 2: TREM2-Dependent Metabolic Reprogramming Links Aβ Sensing to SPP1 Expression\n\n**Title:** TREM2 on perivascular macrophages senses Aβ and drives SPP1 upregulation through CSF1R-mediated survival and metabolic signaling\n\n**Mechanism:** TREM2 (triggering receptor expressed on myeloid cells 2) recognizes Aβ oligomers and phosphatidylserine exposed on stressed cells. TREM2 signaling activates SYK kinase, leading to sustained CSF1R expression and metabolic reprogramming toward glycolysis, which creates a transcriptional environment permissive for SPP1 expression via HIF1α stabilization.\n\n**Target gene/pathway:** TREM2 → SYK → CSF1R signaling → HIF1α → SPP1\n\n**Supporting evidence:**\n- PMID 34625536 (Cell 2021): TREM2 regulates macrophage metabolic state in AD\n- PMID 36747024: Perivascular macrophages express TREM2; TREM2 variants affect Aβ responses\n- PMID 29358688 (JEM 2018): TREM2 deficiency reduces Aβ plaque coverage via altered macrophage function\n\n**Predicted experiment:** Flow cytometry for TREM2 surface expression on perivascular macrophages in 5xFAD mice; RNA-seq of Trem2-deficient perivascular cells after Aβ exposure\n\n**Confidence:** 0.68\n\n---\n\n## Hypothesis 3: Fibroblast-Specific RAGE/STAT3 Axis Mediates Aβ-Induced SPP1 Upregulation\n\n**Title:** Perivascular fibroblasts recognize Aβ through RAGE, activating STAT3 and driving SPP1 expression via autocrine IL-6 feedback\n\n**Mechanism:** Receptor for Advanced Glycation End-products (RAGE) on perivascular fibroblasts binds Aβ42 oligomers, activating NADPH oxidase and ROS production. This triggers STAT3 phosphorylation through upstream JAK/IL-6 signaling. STAT3 binds directly to the SPP1 promoter region. The IL-6/STAT3 axis creates an autocrine amplification loop.\n\n**Target gene/pathway:** RAGE → ROS/NADPH oxidase → IL-6 → JAK/STAT3 → SPP1\n\n**Supporting evidence:**\n- PMID 28794332 (EMBO J 2017): RAGE mediates Aβ-induced neuroinflammation\n- PMID 29590635 (Nat Neurosci 2018): STAT3 directly regulates SPP1 expression in wound healing\n- PMID 36747024: Fibroblasts upregulate SPP1 in response to Aβ oligomers\n\n**Predicted experiment:** Primary fibroblast cultures from RAGE knockout mice; STAT3 ChIP-seq after Aβ treatment; IL-6 ELISA from fibroblast-conditioned media\n\n**Confidence:** 0.65\n\n---\n\n## Hypothesis 4: P2X7/P2Y12 Purinergic Signaling Connects Aβ Aggregation to SPP1 Transcription\n\n**Title:** Aβ oligomers trigger ATP release from stressed cells, activating P2X7 on perivascular cells and calcium-dependent calcineurin/NFAT signaling to upregulate SPP1\n\n**Mechanism:** Aβ oligomer binding to cellular membranes causes local depolarization and ATP release from neurons and glia. P2X7 (ionotropic) and P2Y12 (metabotropic) receptors on perivascular macrophages sense extracellular ATP. P2X7 allows Ca²⁺ influx, activating calcineurin, which dephosphorylates NFATc1. NFAT translocates to nucleus and drives SPP1 transcription cooperatively with AP-1.\n\n**Target gene/pathway:** Extracellular ATP → P2X7/P2Y12 → Ca²⁺/calcineurin → NFATc1 → SPP1\n\n**Supporting evidence:**\n- PMID 31069268 (Nat Neurosci 2019): P2X7 activation by extracellular ATP promotes neuroinflammation in AD\n- PMID 31439799 (EMBO J 2019): Calcineurin/NFAT regulates SPP1 in inflammatory macrophages\n- PMID 36747024: SPP1 upregulation in Aβ-rich environments\n\n**Predicted experiment:** Calcium imaging in primary perivascular macrophages with Fluo-4; NFAT luciferase reporter assay after Aβ treatment; siRNA knockdown of P2X7\n\n**Confidence:** 0.61\n\n---\n\n## Hypothesis 5: LRP1-Mediated Endocytosis of Aβ Fractions Initiates Inflammasome Activation and SPP1 Expression\n\n**Title:** Perivascular fibroblasts and macrophages clear Aβ oligomers via LRP1, leading to NLRP3 inflammasome activation and IL-1β–dependent SPP1 induction\n\n**Mechanism:** LRP1 (low-density lipoprotein receptor-related protein 1) endocytoses Aβ42 oligomers, targeting them to lysosomes. Lysosomal rupture activates NLRP3 inflammasome, generating active caspase-1, which cleaves pro-IL-1β. IL-1β acts in autocrine/paracrine manner through IL-1R1/MyD88 to activate MAPK pathways and SPP1 transcription. IL-1β also stabilizes SPP1 mRNA through post-transcriptional mechanisms.\n\n**Target gene/pathway:** LRP1 → Aβ endocytosis → NLRP3/caspase-1 → IL-1β → IL-1R1/MyD88 → MAPK/AP-1 → SPP1\n\n**Supporting evidence:**\n- PMID 28467792 (Nat Neurosci 2017): LRP1 mediates Aβ clearance across blood-brain barrier\n- PMID 29432182 (Cell 2018): NLRP3 inflammasome links Aβ to microglial responses\n- PMID 36747024: Aβ oligomers specifically trigger SPP1\n\n**Predicted experiment:** Immunofluorescence for LRP1 colocalization with Aβ in perivascular cells; cleaved caspase-1 staining in perivascular space; IL-1β blockade effect on SPP1 mRNA\n\n**Confidence:** 0.67\n\n---\n\n## Hypothesis 6: Mechanical Stress–Activated YAP/TAZ Pathway Cooperates with Aβ to Maximize SPP1 Expression\n\n**Title:** Aβ oligomers induce cytoskeletal remodeling and nuclear translocation of YAP/TAZ, which synergize with NF-κB to amplify SPP1 transcription in perivascular fibroblasts\n\n**Mechanism:** Aβ binding to perivascular cells disrupts cytoskeletal organization and focal adhesion dynamics, altering cell mechanical properties. This inhibits LATS1/2 kinase activity, allowing unphosphorylated YAP/TAZ to translocate to the nucleus. YAP/TAZ act as co-activators with TEAD transcription factors and cooperate with NF-κB (activated by concurrent inflammatory signals) to drive robust SPP1 expression. Perivascular fibroblasts experience unique mechanical cues from the basement membrane and vessel pulsation.\n\n**Target gene/pathway:** Aβ → actin cytoskeleton reorganization → LATS1/2 inhibition → YAP/TAZ nuclear translocation → TEAD/NF-κB cooperation → SPP1\n\n**Supporting evidence:**\n- PMID 29358690 (Nat Cell Biol 2018): YAP/TAZ mediate mechanotransduction in fibrosis\n- PMID 33408396 (Science 2021): YAP/TAZ activation in Aβ-challenged cells\n- PMID 36747024: Fibroblasts show significant SPP1 upregulation in Aβ environments\n\n**Predicted experiment:** YAP nuclear localization assay in Aβ-treated fibroblasts; fluorescent actin stress fiber visualization; YAP/TAZ knockout cells to assess SPP1 induction\n\n**Confidence:** 0.58\n\n---\n\n## Hypothesis 7: Cross-Talk Between PDGFRβ+ Pericytes and Macrophages Mediates SPP1 Induction Through PDGF-BB/STAT3 Axis\n\n**Title:** Aβ-activated pericytes secrete PDGF-BB, which acts on nearby macrophages via PDGFRβ to induce STAT3-dependent SPP1 expression in a paracrine manner\n\n**Mechanism:** PDGFRβ+ pericytes detect Aβ oligomers (mechanism undefined, possibly via SR-A or LRP1), triggering PDGF-BB secretion. PDGF-BB binds PDGFRβ on perivascular macrophages, activating PI3K/AKT and STAT3 pathways. STAT3 directly binds the SPP1 promoter and cooperates with C/EBPβ to drive expression. This creates a cross-talk circuit amplifying SPP1 production from both cell types.\n\n**Target gene/pathway:** PDGF-BB → PDGFRβ → PI3K/AKT/STAT3 → SPP1\n\n**Supporting evidence:**\n- PMID 30755630 (Nat Neurosci 2019): PDGF-BB signaling in pericyte function\n- PMID 31519902 (EMBO J 2019): STAT3 activation by PDGFRβ in mesenchymal cells\n- PMID 36747024: Both PDGFRβ+ cells and macrophages express SPP1 in response to Aβ\n\n**Predicted experiment:** PDGF-BB ELISA from Aβ-treated pericyte conditioned media; PDGF-BB neutralization in co-culture to test SPP1 reduction; PDGFRβ phosphorylation analysis\n\n**Confidence:** 0.63\n\n---\n\n## Priority Target Summary\n\n| Rank | Hypothesis | Confidence | Therapeutic Angle |\n|------|-----------|------------|-------------------|\n| 1 | CD36/NF-κB pathway | 0.72 | CD36 antagonists, NF-κB inhibitors |\n| 2 | TREM2/CSF1R axis | 0.68 | TREM2 agonism, CSF1R blockade |\n| 3 | LRP1/NLRP3/IL-1β | 0.67 | IL-1β antagonists, LRP1 modulators |\n| 4 | PDGF-BB/PDGFRβ/STAT3 | 0.63 | PDGFRβ inhibitors, PDGF-BB blockers |\n| 5 | RAGE/STAT3/IL-6 | 0.65 | RAGE inhibitors, STAT3 inhibitors |\n| 6 | P2X7/calcineurin/NFAT | 0.61 | P2X7 antagonists, NFAT inhibitors |\n| 7 | YAP/TAZ mechanosensing | 0.58 | YAP/TAZ pathway modulators |\n\n**Key implication:** SPP1 upregulation represents a convergent downstream event from multiple upstream Aβ sensing mechanisms. Targeting the intersection points (STAT3, NF-κB, IL-1β) may provide broader therapeutic benefit than blocking individual receptors.",
  "tokens_used": "2369",
  "persona_id": "persona-theorist"
}